Register for our free email digests:
Division of Samsung Electronics Co. Ltd.
Latest From infirst Healthcare Ltd.
Infirst changes the Mylanta Maximum Strength lemon-mint liquid with a "smoother, creamier formulation" and adds a vanilla caramel-flavored version and another liquid product, Mylanta Tonight, featuring a honey chamomile flavor. Also new are Mylanta Gas Minis chewable anti-gas tablets.
Diphenhydramine, a common antihistamine in cough/cold OTCs, proves more effective in suppressing cough than the common antitussive dextromethorphan, researchers say. Diphenhydramine is in FDA’s antitussive OTC monograph, but marketers are criticized for not demonstrating its and other cough/cold ingredients’ efficacy in trials.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March 2015.
Unlike other OTC deals J&J made since McNeil Consumer Healthcare’s quality-control problems led to widespread recalls and a consent decree with FDA, the firm is not divesting the digestive health lines. Infirst will manufacture and market the products in the U.S. for an undisclosed period before the brands return to McNeil.
- Contract Research, Toxicology Testing-CRO
- Therapeutic Areas
- Samsung-Quintiles joint venture
- South Korea
- Pacific Rim
- Parent & Subsidiaries
- Samsung Electronics Co. Ltd.
- Senior Management
Tae Han Kim, PhD, Pres. & CEO
Brian Hosung Min, PhD, VP, Strategic Bus. Dev.
- Contact Info
Phone: 2 2255 8500
300 Songdo Bio Way
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.